DE60117592D1 - Diagnose von pre-eclampsia - Google Patents

Diagnose von pre-eclampsia

Info

Publication number
DE60117592D1
DE60117592D1 DE60117592T DE60117592T DE60117592D1 DE 60117592 D1 DE60117592 D1 DE 60117592D1 DE 60117592 T DE60117592 T DE 60117592T DE 60117592 T DE60117592 T DE 60117592T DE 60117592 D1 DE60117592 D1 DE 60117592D1
Authority
DE
Germany
Prior art keywords
eclampsia
diagnosis
pai
relates
plasminogen activator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60117592T
Other languages
English (en)
Other versions
DE60117592T8 (de
DE60117592T2 (de
Inventor
Lucilla Poston
T Seed
Beverley Hunt
Lucy Chappell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PerkinElmer Health Sciences Inc
Original Assignee
PerkinElmer LAS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PerkinElmer LAS Inc filed Critical PerkinElmer LAS Inc
Publication of DE60117592D1 publication Critical patent/DE60117592D1/de
Application granted granted Critical
Publication of DE60117592T2 publication Critical patent/DE60117592T2/de
Publication of DE60117592T8 publication Critical patent/DE60117592T8/de
Active legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8121—Serpins
    • G01N2333/8132—Plasminogen activator inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
DE60117592T 2000-11-02 2001-11-02 Diagnose von pre-eclampsia Active DE60117592T8 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0026823.5A GB0026823D0 (en) 2000-11-02 2000-11-02 Diagnosis of pre-eclampsia
GB0026823 2000-11-02
PCT/GB2001/004892 WO2002037120A2 (en) 2000-11-02 2001-11-02 Diagnosis of pre-eclampsia

Publications (3)

Publication Number Publication Date
DE60117592D1 true DE60117592D1 (de) 2006-04-27
DE60117592T2 DE60117592T2 (de) 2006-12-21
DE60117592T8 DE60117592T8 (de) 2007-05-10

Family

ID=9902450

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60117592T Active DE60117592T8 (de) 2000-11-02 2001-11-02 Diagnose von pre-eclampsia

Country Status (9)

Country Link
US (3) US7425419B2 (de)
EP (1) EP1330653B1 (de)
AT (1) ATE319094T1 (de)
AU (2) AU2002212495B2 (de)
CA (1) CA2427645C (de)
DE (1) DE60117592T8 (de)
ES (1) ES2256310T3 (de)
GB (1) GB0026823D0 (de)
WO (1) WO2002037120A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7335362B2 (en) 2002-07-19 2008-02-26 Beth Israel Deaconess Medical Center Methods of treating pre-eclampsia or eclampsia
US7435419B2 (en) 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
ES2534926T3 (es) * 2002-07-19 2015-04-30 Beth Israel Deaconess Medical Center Métodos para tratar la preeclampsia
US7320868B2 (en) * 2004-03-19 2008-01-22 Arieh Gertler Leptin binding domain compositions and methods thereto
US8273383B2 (en) * 2004-05-04 2012-09-25 Children's Medical Center Corporation Methods and compositions for treatment of preeclampsia
US7740849B2 (en) 2004-09-24 2010-06-22 Beth Israel Deaconess Medical Center Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of pregnancy related hypertensive disorders
KR20130119506A (ko) 2004-09-24 2013-10-31 베스 이스라엘 데코니스 메디칼 센터 임신성 합병증의 진단 및 치료 방법
WO2007053161A2 (en) * 2004-12-15 2007-05-10 Beth Israel Deaconess Medical Center Nucleic acids and polypeptides useful for diagnosing and treating complications of pregnancy
CN101616927A (zh) * 2005-09-15 2009-12-30 迪爱麦有限公司 诊断先兆子痫的方法
GB0600916D0 (en) 2006-01-17 2006-02-22 Perkinelmer Instr Las Inc detecting and predicting pre-eclampsia
US7790463B2 (en) 2006-02-02 2010-09-07 Yale University Methods of determining whether a pregnant woman is at risk of developing preeclampsia
US20090286271A1 (en) * 2006-05-31 2009-11-19 Karumanchi Ananth S Methods of Diagnosing and Treating Complications of Pregnancy
US20080071151A1 (en) * 2006-06-30 2008-03-20 Sogin David C Method and Apparatus for Diagnosing Pre-eclampsia
GB0715030D0 (en) * 2007-08-02 2007-09-12 Wilson Carol J Testing process
EP2245180B1 (de) 2008-01-25 2014-06-18 PerkinElmer Health Sciences, Inc. Verfahren zur bestimmung des risikos pränataler komplikationen
US20120101021A1 (en) 2009-02-06 2012-04-26 Surendra Sharma Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
GB201013151D0 (en) * 2010-08-04 2010-09-22 Isis Innovation Diagnostic method
JP5924625B2 (ja) 2011-11-15 2016-05-25 国立大学法人浜松医科大学 プラスミノゲンアクチベータインヒビター−１による流産、早産治療薬
CA2872872A1 (en) * 2012-05-17 2013-11-21 Universite Laval Early predictive markers of pre-eclampsia
US10656163B2 (en) 2014-09-02 2020-05-19 Wallac Oy Method for determining risk of pre-eclampsia
CN115015552A (zh) 2015-06-19 2022-09-06 赛拉预测公司 用于预测早产的生物标志物对
CA3073192A1 (en) 2017-08-18 2019-02-21 Sera Prognostics, Inc Pregnancy clock proteins for predicting due date and time to birth
EP4070113A4 (de) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0951298A1 (de) * 1996-12-23 1999-10-27 Cambridge University Technical Services Limited Diagnose und behandlung von pathologischen schwangerschaften

Also Published As

Publication number Publication date
DE60117592T8 (de) 2007-05-10
EP1330653B1 (de) 2006-03-01
US8283451B2 (en) 2012-10-09
EP1330653A2 (de) 2003-07-30
WO2002037120A2 (en) 2002-05-10
WO2002037120A3 (en) 2002-10-17
AU1249502A (en) 2002-05-15
US20090011429A1 (en) 2009-01-08
AU2002212495B2 (en) 2006-04-13
US8017734B2 (en) 2011-09-13
ATE319094T1 (de) 2006-03-15
DE60117592T2 (de) 2006-12-21
CA2427645C (en) 2011-03-08
GB0026823D0 (en) 2000-12-20
ES2256310T3 (es) 2006-07-16
CA2427645A1 (en) 2002-05-10
US7425419B2 (en) 2008-09-16
US20040038305A1 (en) 2004-02-26
US20110300564A1 (en) 2011-12-08

Similar Documents

Publication Publication Date Title
DE60117592T8 (de) Diagnose von pre-eclampsia
DE502005007863D1 (de) P1gf und flt-1 als prognostische parameter bei kardiovaskulären erkrankungen
EP1687283A4 (de) Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung
MXPA05010325A (es) Analisis proteomico de fluidos biologicos.
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
ATE310955T1 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten
AU3084802A (en) Inflammatory markers as tools in the detection and prevention of diabetes mellitus and as tools to aid in the selection of agents to be used for the prevention and treatment of diabetes
WO2006030232A3 (en) Monitoring of wounds by measurement of protease and protease inhibitor levels in wound fluids
DE60021068D1 (de) Gewebeinhibitor der matrix-metalproteinase typ 1 (timp-1) als krebsmarker
WO2004043223A3 (en) Compositions and methods for the diagnosis and treatment of sepsis
WO2001055719A3 (en) Diagnostic kit for detecting creatine levels
ATE282831T1 (de) Verfahren zur diagnose von sepsis unter bestimmung löslicher cytokeratinfragmente
GB0319167D0 (en) Diagnostic method for stroke
NO964015L (no) Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer
SE9604815D0 (sv) A metod of diagnosis
ATE466020T1 (de) Neue isoform des gefässendothelzell wachstumshemmers (vegi)
HK1040429A1 (en) Tau as a marker for early cns damage.
ATE494556T1 (de) Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1
DK0720745T3 (da) Fremgangsmåde til kvantificering af ekstracellulært BPI i legemsvæsker
DE60126991D1 (de) Verfahren ZUR DIAGNOSE VON SCHIZOPHRENIE
DE59709109D1 (de) Monoklonale antikörper gegen einen komplex aus humanem act und einer serinprotease
ATE503999T1 (de) Stabiles, chromogenes testreagenz und dessen verwendung in gerinnungsdiagnostischen tests
DK1031035T3 (da) Haptoglobin assay
EP1141703A4 (de) Verfahren zum bestimmen eines erhöhten risikos einer frau ein "down-syndrom" zu tragen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8381 Inventor (new situation)

Inventor name: POSTON, LUCILLA, MATERNAL AND FETAL RESEARCH U, GB

Inventor name: SEED, PAUL T., MATERNAL AND FETAL RESEARCH UNI, GB

Inventor name: HUNT, BEVERLY, MATERNAL AND FETAL RESEARCH UNI, GB

Inventor name: CHAPPELL, LUCY, MATERNAL AND FETAL RESEARCH UN, GB